Validation of prescribing appropriateness criteria for older Australians using the RAND/UCLA appropriateness method

BMJ Open

Volumn 2, Issue 5, 2012, Pages

  Basger, Benjamin Joseph ^a   Chen, Timothy Frank ^a   Moles, Rebekah Jane ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLIBENCLAMIDE; HALOPERIDOL; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLUENZA VACCINE; ISOSORBIDE DINITRATE; METFORMIN; METHENAMINE; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; PNEUMOCOCCUS VACCINE; PROTEINASE INHIBITOR; SALBUTAMOL; SEROTONIN UPTAKE INHIBITOR; SIMVASTATIN; UNINDEXED DRUG; VITAMIN D;

ANTICHOLINERGIC EFFECT; ARTICLE; AUSTRALIA; EVIDENCE BASED PRACTICE; HEALTH CARE PERSONNEL; HUMAN; INFLUENZA; LOW DRUG DOSE; PNEUMOCOCCAL INFECTION; PRESCRIPTION;

EID: 84869785795     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-001431     Document Type: Article

References (139)

1. Kwint H-F, Faber A, Gussekloo J, et al. Effects of medication review on drug-related problems in patients using automated drug-dispensing systems. Drugs Aging 2011;28:305-14.
2. Ellitt GR, Engblom E, Aslani P, et al. Drug related problems after discharge from an Australian teaching hospital. Pharm World Sci 2010;32:622-30.
3. Nishtala PS, McLachlan AJ, Bell JS, et al. A retrospective study of drug-related problems in Australian aged care homes: medication reviews involving pharmacists and general practitioners J Eval Clin Pract 2011;17:97-103.
4. Stafford AC, Tenni PC, Peterson GM, et al. Drug-related problems identified in medication reviews by Australian pharmacists. Pharm World Sci 2009;31:216-23.
5. Hilmer SN, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther 2009;85:86-8.
6. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004;329:15-19.
7. Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother 2008;42:1017-25.
8. Castelino RL, Chen TF, Guddattu V, et al. Use of evidence-based therapy for the prevention of cardiovascular events among older people. Eval Health Prof 2010;33:276-301.
9. Heeley EL, Peiris DP, Patel AA, et al. Cardiovascular risk perception and evidence-practice gaps in Australian general practice (the AusHEART study). MJA 2010;192:254-9.
10. National Institute of Clinical Studies, Australian Government. Evidence-practice gaps report, vol. 1. A review of developments 2004-2007. 2008. http://www.nhmrc.gov.au/nics/materials-and-resources/evidence-practice-gaps- report-volume-one-review-developments-2004-2007 (accessed 18 Jul 2012).
11. Gilbert AL, Roughead EE, Beilby J, et al. Collaborative medication management services: improving patient care. MJA 2002;177:189-92.
12. Elliott RA, Martinac G, Campbell S, et al. Pharmacist-led medication review to identify medication-related problems in older people referred to an aged care assessment team. A randomiized comparative study. Drugs Aging 2012;29:593-605.
13. Kaur S, Mitchell G, Vitetta L, et al. Interventions that can reduce inappropriate prescribing in the elderly. Drugs Aging 2009;26:1013-28.
14. Tulner LR, van Campen JPCM, Frankfort SV, et al. Changes in under-treatment after comprehensive geriatric assessment. An observational study. Drugs Aging 2010;27:831-43.
15. Le Couteur DG, Banks E, Gnjidic D, et al. Deprescribing. Aust Presc 2011;34:182-5.
16. Garfinkel D, Mangin D. Feasibility study of a systemic approach for discontinuation of multiple medications in older adults. Arch Intern Med 2010;170:1648-54.
17. Gill JM, Mainous AG, Koopman RJ, et al. Impact of EHR-based clinical decision support on adherence to guidelines for patients on NSAID's: a randomised controlled trial. Ann Fam Med 2011;9:22-30.
18. O'Connor PJ, Sperl-Hillen JM, Rush WA, et al. Impact of elecronic health record clinical decision support on diabetes care; a randomised trial. Ann Fam Med 2011;9:12-21.
19. Chang C-B, Chan D-C. Comparison of published explicit criteria for potentially inappropriate medications in older adults. Drugs Aging 2010;27:947-57.
20. Scott I, Jayathissa S. Quality of drug prescribing in older patients: is there a problem and can we improve it? Intern Med J 2010;40:7-18.
21. Gallagher P, Ryan C, Byrne S, et al. STOPP (screening tool of older person's prescriptions) and START (screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther 2008;46:72-83.
22. American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. The American Geriatrics Society 2012 Beers Criteria update expert panel. J Am Geriatr Soc 2012;60:616-31.
23. Medicare Australia [homepage on the internet]. Australian Government. Home Medicines Review. http://www. medicareaustralia.gov.au/provider/pbs/fourth- agreement/hmr.jsp (accessed 17 Jul 2012).
24. Pharmaceutical Society of Australia. Guidelines for pharmacists providing Residential Medication Management Review (RMMR) and Quality Use of Medicines (QUM) services. 2011. http://www.psa.org.au/download/practice-guidelines/rmmr- and-qum-services.pdf (accessed 17 Aug 2012).
25. Basger BJ, Chen TF, Moles RJ. Inappropriate medication use and prescribing indicators in elderly Australians. Drugs Aging 2008;25:777-93.
26. Chang C-B, Chen J-H, Wen C-J, et al. Potentially inappropriate medications in geriatric outpatients with polypharmacy: application of six sets of published explicit criteria. Br J Clin Pharmacol 2011;72:482-89.
27. Laroche ML, Charmes JP, Bouthier JP, et al. Inappropriate medications in the elderly. Clin Pharmacol Ther 2009;85:94-7.
28. Maio V, Jutkowitz E, Herrera K, et al. Appropriate medication prescribing in elderly patients: how knowledgeable are primary care physicians? A survey study in Parma, Italy. J Clin Pharm Ther 2011;36:468-80.
29. Resnick B, Pacala JT. 2012 Beers criteria. J Am Geriatr Soc 2012;60:612-13.
30. Fried TR, Tinetti ME, Iannone MA. Primary care clinicians experiences with treatment decision making for older persons with multiple conditions. Arch Intern Med 2011;171:75-80.
31. Hayward RA. Performance measurement in search of a path. N Eng J Med 2007;356:951-2.
32. Dimitrow MS, Airaksinen MSA, Kivela S-L, et al. Comparison of prescribing criteria to evaluate the appropriateness of drug treatment in individuals aged 65 and older: a systematic review. J Am Geriatr Soc 2011;59:1521-30.
33. Mangin D, Sweeney K, Heath I. Preventative health care in elderly people needs rethinking. BMJ 2007;335:285-7.
34. Scott IA, Guyatt GH. Cautionary tales in the interpretation of clinical studies involving older persons. Arch Intern Med 2010;170:587-95.
35. Martirosyan L, Voorham J, Haaijer-Ruskamp FM, et al. A systematic literature review: prescribing indicators related to type 2 diabetes mellitus and cardiovascular risk management. Pharmacoepidemiol Drug Saf 2010;19:319-34.
36. Bettering the evaluation and care of health (BEACH). Family Medicine Research Centre. The University of Sydney. http://sydney.edu.au/medicine/fmrc/ beach/ (accessed 18 Jul 2012).
37. Access to Pharmaceutical Services. Pharmaceutical Benefits Scheme. Department of Health and Ageing. Australian Government. http://www.health.gov. au/internet/budget/publishing.nsf/Content/2010-11-Health-PBS-sup1/$File/ Outcome%202%20-%20Access%20to%20Pharmaceutical%20Services.pdf (accessed 10 Jul 2012).
38. eTG complete [CD-ROM]. Melbourne (VIC): Therapeutic Guidelines: 2011 Nov.
39. Rossi S, ed. Australian Medicines Handbook 2012 (CD-ROM). Adelaide: Australian Medicines Handbook Pty Ltd, 2012.
40. NSW Therapeutic Advisory Group. Indicators for Quality Use of Medicines in Australian Hospitals 2007 http://www.ciap.health.nsw.gov.au/nswtag/documents/ publications/QUMIndicators/ Manual0408.pdf (accessed 18 Jul 2012).
41. Fitch K, Bernstein SJ, Aguilar MS, et al. The RAND/UCLA Appropriateness Method User's Manual 2001. Rand Corporation. http://www.rand.org/pubs/monograph- reports/MR1269.html (accessed 18 Jul 2012).
42. McGory ML, Kao KK, Shekelle PG, et al. Developing quality indicators for elderly surgical patients. Ann Surg 2009;250:338-47.
43. SooHoo NF, Lieberman JR, Farng E, et al. Development of quality of care indicators for patients undergoing total hip or total knee replacement. Qual Saf 2011;20:153-7.
44. Avery AJ, Dex GM, Mulvaney C, et al. Development of prescribing-safety indicators got GPs using the RAND appropriateness method. Brit J Gen Pract 2011;61:526-36.
45. Levy HB, Marcus E-L, Christen C. Beyond the Beers criteria: a comparative overview of explicit criteria. Ann Pharmacother 2010;44:1968-75.
46. Shekelle PG. Appropriateness criteria: a useful tool for the cardiologist. Heart 2009;95:517-20.
47. Hypertension and target blood pressure. National Prescribing Service. Indicators of quality prescribing in Australian general practice. A Manual for Users [online]. http://www.nps.org.au/-data/assets/pdf-file/0019/37351/ indicators-full.pdf (accessed 18 Jul 2012).
48. Heart Foundation Guide to management of hypertension 2008. Updated December 2010. http://www.heartfoundation.org.au/SiteCollectionDocuments/ HypertensionGuidelines2008to 2010Update.pdf (accessed 18 Jul 2012).
49. Rossi S, ed. Australian medicines handbook drug choice companion: aged care. 3rd edn. Adelaide: Australian Medicines Handbook Pty Ltd, 2010.
50. Charpentier MM, Bundeff MM. Treating hypertension in the very elderly. Ann Pharmacother 2011;45:1138-45.
51. Gribbin J, Hubbard R, Gladman JRF, et al. Risk of falls associated with antihypertensive medication; population-based case control study. Age Ageing 2010;39:592-7.
52. Tinetti ME, Kumar C. The patient who falls. JAMA 2010;303:258-66.
53. Therapeutics Initiative. Do statins have a role in primary prevention? An update. Ther Lett 2010;77:1-5. http://www.ti.ubc.ca/sites/ti.ubc.ca/files/77. pdf (accessed 18 Jul 2012).
54. Ray KK, Seshasai SRK, Erqou S, et al. Statins and all-cause mortality in high-risk primary prevention. A meta-analysis of 11 randomised controlled trials involving 65,229 participants. Arch Intern Med 2010;170:1024-31.
55. deLorgeril M, Salen P, Abramson J, et al. Cholesterol lowering, cardiovascular diseases, and the rosuvastatin-JUPITER controversy. A critical reappraisal. Arch Intern Med 2010;170:1032-6.
56. Petersen LK, Christensen K, Kragstrup J. Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds. Age Ageing 2010;39:674-80.
57. Robinson JG. Lipid-lowering therapy for the primary prevention of cardiovascular disease in the elderly. Opportunities and challenges. Drugs Aging 2009;26:917-31.
58. Krum H, Jelinek M, Stewart S, et al. 2011 Update to National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand guidelines for the prevention, detection and management of chronic heart failure in Australia 2006. MJA 2011;194:405-9.
59. Krum H, Teerlink JR. Medical therapy for chronic heart failure. Lancet 2011;378:713-21.
60. Huang D, Cheng JWM. Pharmacologic management of heart failure with preserved ejection fraction. Ann Pharmacother 2010;44:1933-45.
61. Management of diastolic heart failure [revised 2008 June]. In: eTG complete [CD-ROM]. Melbourne: Therapeutic Guidelines Limited, 2011.
62. Huang N, Duggan K, Harman J. Lifestyle management of hypertension. Aust Presc 2008;31:150-3.
63. Stokes GS. Management of hypertension in the elderly patient. Clin Interv Aging 2009;4:379-89.
64. Bajorek BV, Krass I, Ogle SJ, et al. Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: a pharmacist-led multidisciplinary intervention. J Am Geriatr Soc 2005;53:1912-20.
65. De Caterina R, Hylek EM. Stroke prevention in atrial fibrillation: current status and near-future directions. Am J Med 2011;124:793-9.
66. Gillett RG, Norrell A. Considerations for safe use of statins: liver enzyme abnormalities and muscle toxicity. Am Fam Physician 2011;83:711-16.
67. Thomas JE, Tershakovec AM, Jones-Burton C, et al. Lipid lowering for secondary prevention of cardiovascular disease in older adults. Drugs Aging 2010;27:959-72.
68. Perrotta C, Aznar M, Mejia R, et al. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev2008; (2): CD005131. doi:10.1002/14651858.CD005131.pub2
69. Treatment of hypothyroidism [revised 2009 June]. In: eTG complete [CD-ROM]. Melbourne: Therapeutic Guidelines Limited, 2011.
70. Reducing Risk in Heart Disease 2007. A summary guide for preventing cardiovascular events in people with coronary heart disease. Updated 2008. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand. http://www.heartfoundation.org.au/information-for-professionals/ Clinical-Information/Pages/coronary-heart-disease.aspx (accessed 12 Jul 2012).
71. Volpe M. Should all patients at high cardiovascular risk receive renin-angiotensin system blockers? Q J Med 2012;105:11-27.
72. Boyd CM, Leff B, Wolff JL, et al. Informing clinical practice guideline development and implementation: prevalence of coexisting conditions among adults with coronary heart disease. J Am Geriatr Soc 2011;59:797-805.
73. Heart Foundation. Guide to management of Hypertension 2008 updated 2010 [online].http://www.heartfoundation.org.au/SiteCollectionDocuments/ HypertensionGuidelines2008to2010 Update.pdf (accessed 18 Jul 2012).
74. Guidelines for the assessment of absolute cardiovascular disease risk. http://www.heartfoundation.org.au/SiteCollectionDocuments/guidelines-Absolute- risk.pdf (accessed 18 Jul 2012).
75. Holmes HM. Rational prescribing for patients with a reduced life expectancy. Clin Pharmacol Ther 2009;85:103-7.
76. Improving treatment of systolic heart failure. NPS News 75, 2011. National Prescribing Service Limited. http://www.nps.org.au/-data/assets/pdf- file/0006/132495/News75-heart-failure-1011v2.pdf (accessed 18 Jul 2012).
77. Caughey GE, Roughead EE, Shakib S, et al. Co-morbidity and potential treatment conflicts in elderly heart failure patients. Drugs Aging 2011;28:575-81.
78. Lip GYH, Halperin JL. Improving stroke risk stratification in atrial fibrillation. Am J Med 2010;123:484-8.
79. Hughes M, Lip GYH. Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review. Q J Med 2007;100:599-607.
80. Adverse Drug Reactions Advisory Committee. Statins and muscle disorders - be careful with the dose. Aust Adverse Drug React Bull 2008;27. http://www.tga.gov.au/pdf/aadrb-0806.pdf (accessed 18 Jul 2012).
81. LeChauncy WD, Landrum CR, Urech TH, et al. Treating chronically ill people with diabetes mellitus with limited life expectancy: Implications for performance measurement. J Am Geriatr Soc 2012;60:193-201.
82. Lee SJ, Boscardin WJ, Cenzer IS, et al. The risks and benefits of implementing glycemic control guidelines in frail older adults with diabetes mellitus. J Am Geriatr Soc 2011;59:666-72.
83. Joint Formulary Committee. British National Formulary (online) London: BMJ Group and Pharmaceutical Press 〈http://www. medicinescomplete.com〉 (accessed 18 Jul 2012).
84. Analgesic choices in persistent pain. Prescribing Pract Rev 2006;35. National Prescribing Service Limited http://www.nps.org. au/-data/assets/pdf- file/0017/23750/ppr35-analgesics-0906.pdf (accessed 18 Jul 2012).
85. Hill KD, Wee R. Psychotropic drug-induced falls in older people. A review of interventions aimed at reducing the problem. Drugs Aging 2012;29:15-30.
86. Zeimer H. Medications and falls in older people. J Pharm Pract Res 2008;38:148-51.
87. Caughey GE, Roughead EE, Shakib S, et al. Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressants. Age Ageing 2010;39:488-94.
88. Proton pump inhibitors. NPS News 46, 2006. National Prescribing Service Limited. http://www.nps.org.au/-data/assets/pdf-file/0016/23821/news46-gord- ppis-0606.pdf (accessed 18 Jul 2012).
89. National Asthma Council Australia. Asthma Management Handbook 2006. Australia, Melbourne: National Asthma Council, 2006 http://www.nationalasthma. org.au/uploads/handbook/370-amh2006-web-5.pdf (accessed 18 Jul 2012).
90. Inderjeeth CA, Poland KE. Management of osteoporosis in older people. J Pharm Pract Res 2010;40:229-34.
91. Reducing fracture risk in osteoporosis. NPS News 73, 2011. National Prescribing Service Limited. http://www.nps.org.au/-data/assets/pdf-file/0014/ 126401/News73-osteoporosis-0511.pdf (accessed 18 Jul 2012).
92. Gates BJ, Sonnett TE, DuVall CAK, et al. Review of osteoporosis pharmacotherapy for geriatric patients. Am J Geriatr Pharmacother 2009;7:293-323.
93. Cheung AM, Detsky AS. Osteoporosis and fractures-missing the bridge? JAMA 2008;299:1468-70.
94. Commonwealth of Australia. The National Strategy for Quality Use of Medicines Plain English Edition [online]. http://www.health.gov. au/internet/main/Publishing.nsf/Content/CA777524C860DFF2CA256F1800468B61/ $File/natstrateng.pdf (accessed 18 Jul 2012).
95. Basger BJ, Chen TF, Moles RJ. Application of a prescribing indicators tool to assist in identifying drug-related problems in a cohort of older Australians. Int J Pharm Pract 2012;20:172-82.
96. Caughey GE, Vitry AI, Gilbert AL, et al. Prevalence of comorbidity of chronic diseases in Australia. BMC Public Health 2008. http:// www.biomedcentral.com/1471-2458/8/221 (accessed 18 Jul 2012).
97. Top 40 most frequently managed problems: Patients aged 65+. Personal communication, unpublished data from the BEACH Program, Family Medicine Research Centre, University of Sydney, November 2011. http://sydney.edu.au/medicine/ fmrc/beach/index.php (accessed 10 Jul 2012).
98. Evidence-practice gaps report. Vol. 2. National Institute of Clinical Studies. Australian Government 2005. http://www.nhmrc.gov.au/nics/material- resources/resources/evidence-volume-two.htm (accessed 12 Jul 2012).
99. Evidence-practice gaps report. Vol. 1. National Institute of Clinical Studies, Australian Government 2003. http://www.nhmrc.gov.au/nics/material- resources/resources/evidence-volume-one.htm (accessed 17 July 2012).
100. Evidence-practice gaps report. Vol 1. A review of developments: 2004-2007. National Institute of Clinical Studies. Australian Government. http://www.nhmrc.gov.au/nics/materials-and-resources/evidence-practice-gaps- report-volume-one-review-developments-2004-2007 (accessed 17 July 2012).
101. Bajorek BV, Ren S. Utilisation of antithrombotic therapy for stroke prevention in atrial fibrillation in a Sydney hospital: then and now. Int J Clin Pharm 2012;34:88-97.
102. O'Connor MN, Gallagher P, O'Mahony D. Inappropriate prescribing. Criteria, detection and prevention. Drugs Aging 2012;29:437-52.
103. Castelino RL, Bajorek BV, Chen TF. Retrospective evaluation of home medicine review by pharmacists in older Australian Patients using the Medication Appropriateness Index. Ann Pharmacother 2010;44:1922-9.
104. King MA, Roberts MS. The influence of the Pharmaceutical Benefits Scheme (PBS) on inappropriate prescribing in Australian nursing homes. Phar World Sci 2007;29:39-42.
105. Stafford AC, Alswayan MS, Tenni PC. Inappropriate prescribing in older residents of Australian care homes. J Clin Pharm Ther 2011;36:33-44.
106. Widagdo IS, Nyfort-Hansen K, Kowalski SR. Prevalence of potentially inappropriate medication use in elderly hospitalised patients. J Pharm Pract Res 2011;41:122-5.
107. Roughead EE, Anderson B, Gilbert AL. Potentially inappropriate prescribing among Australian veterans and war widows/widowers. Intern Med J 2007;37:402-5.
108. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003;163:2716-24.
109. Ryan C, O'Mahony D, Kennedy J, et al. Appropriate prescribing in the elderly: an investigation of two screening tools, Beers criteria considering diagnosis and independent of diagnosis and improving prescribing in the elderly tool to identify inappropriate use of medicines in the elderly in primary care in Ireland. J Clin Pharm Ther 2009;34:369-76.
110. Ionescu-Ittu R, Abrahamowicz M, Jackevicius CA, et al. Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation. Arch Intern Med 2012;172:997-1004.
111. Page RL, Linnebur SA, Bryant LL, et al. Inappropriate prescribing in the hospitalised elderly patient: defining the problem, evaluation tools, and possible solutions. Clin Interv Aging 2010;5:75-87.
112. Holt S, Schmiedl S, Thurmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arzteblatt Int 2010;107:543-51.
113. Laroche ML, Charmes JP, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 2007;63:725-31.
114. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997;157:1531-6.
115. Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric MedicineArch Intern Med 1991;151:1825-32.
116. McLeod PJ, Huang AR, Tamblyn RM, et al. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997;156:385-91.
117. Zhan C, Sangl J, Bierman AS, et al. Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA 2001;286:2823-9.
118. Starfield B, Lemke KW, Herbert R, et al. Comorbidity and the use of primar care and specialist care in the elderly. Ann Fam Med 2005;3:215-22.
119. Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 2012;380:37-43.
120. Evans SM, Lowinger JS, Sprivulis PC, et al. Prioritizing quality indicator development across the healthcare system: identifying what to measure. Intern Med J 2009;39:648-54.
121. Elliott RA, Woodward MC, Oborne CA. Indicators of prescribing quality for elderly hospital inpatients. Aust J Hosp Pharm 2001;31:19-25.
122. National Prescribing Service. Indicators of quality prescribing in Australian general practice 2006. A Manual for Users. http://www.nps.org.au/- data/assets/pdf-file/0019/37351/indicators-full.pdf (accessed 18 Jul 2012).
123. A proposed set of clinical indicators for stakeholder comment by 30 July 2012. RACGP clinical improvement unit practice, policy and innovation department. The Royal Australian College of General Practitioners. http://www.racgp.org.au/Content/NavigationMenu/ClinicalResources/ Clinicalindicators/2012ClinicalIndicators-ConsultationPaper.pdf (accessed 16 Jul 2012).
124. Morris CJ, Cantrill JA, Hepler CD, et al. Preventing drug-related morbidity - determining valid indicators. Int J Qual Health Care 2002;14:183-98.
125. Bell JS, Le Couteur DG, McLachlan AJ, et al. Improving medicine selection for older people. Do we need an Australian classification for inappropriate medicines use? Aust Fam Physician 2012;41:9-10.
126. Britt H, Miller GC, Charles J, et al. General practice activity in Australia 2000-1 to 2009-10: 10 year data tables. General practice series no. 28. Cat. no. GEP 28. Canberra: AIHW, 2010. http://www. aihw.gov.au/publication- detail/?id=6442472440&tab=2 (accessed 17 Jul 2012).
127. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases. JAMA 2005;294:716-24.
128. Kamerow D. How can we treat multiple chronic conditions? BMJ 2012;344:e1487. doi:10.136/bmj.e87
129. Richmond RL, Law J, Kay-Lambkin F. Physical, mental, and cognitive function in a convenience sample of centenarians in Australia. J Am Geriatr Soc 2011;59:1080-6.
130. Wastesson JW, Parker MG, Fastbom J, et al. Drug use in centenarians compared with nonagenarians and octogenarians in Sweden: a nationwide register-based study. Age Ageing 2012;41:218-24.
131. Watts G. Why the exclusion of older people from clinical research must stop. BMJ 2012;344:e3445.
132. Frada G, Bennati E, Cardillo E, et al. Pharmacotherapy in the extreme longevity. Arch Gerontol Geriatr 2009;49:60-3.
133. Campbell SM, Braspenning J, Hutchinson A, et al. Research methods used in developing and applying quality indicators in primary care. Qual Saf Health Care 2002;11:358-64.
134. Vitry AI, Zhang Y. Quality of Australian clinical guidelines and relevance to the care of older people with multiple comorbid conditions. Med J Aust 2008;189:360-5.
135. Lee SJ, Walter LC. Quality indicators for older adults. Preventing unintended harms. JAMA 2011;306:1481-2.
136. Gilbert AL, Caughey GE, Vitry AI, et al. Ageing well: improving the management of patients with multiple chronic health problems. Australas J Ageing 2011;30(S2):32-7.
137. Gnjidic D, Hilmer SN, Blyth FM, et al. High-risk prescribing and incidence of frailty among older community-dwelling men. Clin Pharmacol Ther 2012;91:521-8.
138. Sirois C, Moisan J, Poirier P, et al. Association between age and the initiation of antihypertensive, lipid lowering and antiplatelet medications in elderly individuals newly treated with antidiabetic drugs. Age Ageing 2009;38:741-5.
139. Powers JH. Practice guidelines. Belief, criticism, and probability. Arch Intern Med 2011;171:15-16.